EP0979309A4 - Oligonukleotide mit verbesserter bioverfügbarkeit - Google Patents
Oligonukleotide mit verbesserter bioverfügbarkeitInfo
- Publication number
- EP0979309A4 EP0979309A4 EP98920076A EP98920076A EP0979309A4 EP 0979309 A4 EP0979309 A4 EP 0979309A4 EP 98920076 A EP98920076 A EP 98920076A EP 98920076 A EP98920076 A EP 98920076A EP 0979309 A4 EP0979309 A4 EP 0979309A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- oligonucleotides
- enhanced bioavailability
- alimentary delivery
- oligonucleotide
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
- C12N2310/3341—5-Methylcytosine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US847151 | 1992-03-05 | ||
US84715197A | 1997-04-30 | 1997-04-30 | |
PCT/US1998/008798 WO1998049348A1 (en) | 1997-04-30 | 1998-04-30 | Oligonucleotides for enhanced bioavailability |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0979309A1 EP0979309A1 (de) | 2000-02-16 |
EP0979309A4 true EP0979309A4 (de) | 2000-10-18 |
Family
ID=25299899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98920076A Ceased EP0979309A4 (de) | 1997-04-30 | 1998-04-30 | Oligonukleotide mit verbesserter bioverfügbarkeit |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0979309A4 (de) |
JP (1) | JP2000514095A (de) |
KR (1) | KR20010020370A (de) |
AU (1) | AU738352B2 (de) |
CA (1) | CA2286396C (de) |
WO (1) | WO1998049348A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887906B1 (en) | 1997-07-01 | 2005-05-03 | Isispharmaceuticals, Inc. | Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
EP1080225A4 (de) * | 1998-05-21 | 2004-02-04 | Isis Pharmaceuticals Inc | Zusammensetzungen und methoden zur pulmonalen verabreichung von nukleinsäuren |
SI1077722T1 (sl) | 1998-05-22 | 2007-02-28 | Ottawa Health Research Inst | Metode in produkti za induciranje sluznicne imunosti |
WO2000050050A1 (en) * | 1999-02-23 | 2000-08-31 | Isis Pharmaceuticals, Inc. | Multiparticulate formulation |
US6168950B1 (en) * | 1999-07-23 | 2001-01-02 | Isis Pharmaceuticals, Inc. | Antisense modulation of MEKK1 expression |
ES2302699T3 (es) * | 1999-08-27 | 2008-08-01 | Novartis Vaccines And Diagnostics, Inc. | Oligonucleotidos quimericos antisentido y formulaciones de transfeccion celular de los mismos. |
US6677445B1 (en) | 1999-08-27 | 2004-01-13 | Chiron Corporation | Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
IL159722A0 (en) | 2001-07-10 | 2004-06-20 | Oligos Etc Inc | Pharmaceutical compositions containing oligonucleotides |
US20030124196A1 (en) | 2001-08-22 | 2003-07-03 | Susan Weinbach | Pulsatile release compositions and methods for enhanced intestinal drug absorption |
MX2011005042A (es) | 2008-11-13 | 2011-08-17 | Giuliani Int Ltd | Composiciones antisentido, y metodos para obtener y usar las mismas. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0626387A1 (de) * | 1993-05-12 | 1994-11-30 | Ciba-Geigy Ag | Nukleoside und Oligonukleotide mit 2'-Ethergruppen |
WO1995002069A1 (en) * | 1993-07-09 | 1995-01-19 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of protein kinase c |
WO1996012497A1 (en) * | 1994-10-25 | 1996-05-02 | Hybridon, Inc. | Use of 2'-substituted oligonucleotides to down-regulating gene expression |
WO1997029780A1 (en) * | 1996-02-14 | 1997-08-21 | Isis Pharmaceuticals, Inc. | Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5214135A (en) * | 1991-08-30 | 1993-05-25 | Chemgenes Corporation | N-protected-2'-O-methyl-ribonucleosides and N-protected 2'-O-methyl-3'-cyanoethyl-N-,N-diisopropyl phosphoramidite ribonucleosides |
DE69629702T2 (de) * | 1995-08-01 | 2004-06-17 | Isis Pharmaceuticals, Inc., Carlsbad | Liposomale oligonukleotidzusammensetzungen |
-
1998
- 1998-04-30 KR KR1019997009992A patent/KR20010020370A/ko not_active Application Discontinuation
- 1998-04-30 EP EP98920076A patent/EP0979309A4/de not_active Ceased
- 1998-04-30 WO PCT/US1998/008798 patent/WO1998049348A1/en not_active Application Discontinuation
- 1998-04-30 CA CA2286396A patent/CA2286396C/en not_active Expired - Fee Related
- 1998-04-30 AU AU72723/98A patent/AU738352B2/en not_active Ceased
- 1998-04-30 JP JP10547416A patent/JP2000514095A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0626387A1 (de) * | 1993-05-12 | 1994-11-30 | Ciba-Geigy Ag | Nukleoside und Oligonukleotide mit 2'-Ethergruppen |
WO1995002069A1 (en) * | 1993-07-09 | 1995-01-19 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of protein kinase c |
WO1996012497A1 (en) * | 1994-10-25 | 1996-05-02 | Hybridon, Inc. | Use of 2'-substituted oligonucleotides to down-regulating gene expression |
WO1997029780A1 (en) * | 1996-02-14 | 1997-08-21 | Isis Pharmaceuticals, Inc. | Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
Non-Patent Citations (2)
Title |
---|
MARTIN P: "38. EIN NEUER ZUGANG ZU 2'-O-ALKYLRIBONUCLEOSIDEN UND EIGENSCHAFTEN DEREN OLIGONUCLEOTIDE", HELVETICA CHIMICA ACTA,CH,VERLAG HELVETICA CHIMICA ACTA. BASEL, vol. 78, 1995, pages 486 - 504, XP000857415, ISSN: 0018-019X * |
See also references of WO9849348A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0979309A1 (de) | 2000-02-16 |
WO1998049348A1 (en) | 1998-11-05 |
CA2286396C (en) | 2010-07-06 |
AU7272398A (en) | 1998-11-24 |
JP2000514095A (ja) | 2000-10-24 |
KR20010020370A (ko) | 2001-03-15 |
AU738352B2 (en) | 2001-09-13 |
CA2286396A1 (en) | 1998-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA01004876A (es) | Producto comestible refrescante de aliento. | |
ZA200200743B (en) | Preserved pharmaceutical formulations. | |
ZA200300791B (en) | Confectionery product containing active ingredients. | |
PL351623A1 (en) | Mousse forming hair treatment composition | |
ZA983497B (en) | Activated protein c formulations. | |
ZA982253B (en) | Therapeutic compositions. | |
ZA993338B (en) | Pharmaceutical formulations. | |
HK1030753A1 (en) | Fracture healing using pthrp analogs. | |
ZA200202996B (en) | Hair treatment compositions comprising particulate substances. | |
ZA200202476B (en) | Tissue products containing antiviral agents which are mild to the skin. | |
ZA200006169B (en) | Edible fat based flakes. | |
EP1435982A4 (de) | System zur abgabe von pharmazeutischen, ernährungs- und kosmetischen inhaltsstoffen | |
MXPA01012478A (es) | Formulaciones farmaceuticas mejoradas. | |
EP0979309A4 (de) | Oligonukleotide mit verbesserter bioverfügbarkeit | |
HK1040980A1 (zh) | 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途 | |
ZA200109348B (en) | Noninvasive genetic immunization, expression products therefrom, and uses thereof. | |
PL349393A1 (en) | Sulphonyloxazolamines as therapeutic active ingredients | |
HK1022853A1 (en) | Pharmaceutical compositions. | |
HK1040488A1 (en) | Pharmaceutical formulations. | |
EP2191839A3 (de) | Immunogene LHRH Zusammensetzungen sowie damit zusammenhängende Verfahren | |
EP1129725A3 (de) | Oligonukleotid-Konjugate | |
WO2001014415A3 (en) | Egfh2 genes and gene products | |
AU6082800A (en) | Edible animal muscle protein gels | |
ZA99168B (en) | Pharmaceutical formulations and processes for their preparation. | |
MXPA01012500A (es) | Productos para terapia de gen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19991126 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ECKER, DAVID, J. Inventor name: BAKER, BRENDA, F. Inventor name: ANDERSON, KEVIN, P. Inventor name: DRAPER, KENNETH Inventor name: MONIA, BRETT, P. Inventor name: BENNETT, C., FRANK Inventor name: DEAN, NICHOLAS, M. |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 12Q 1/68 A, 7C 12N 15/00 B, 7C 12N 15/63 B, 7C 12N 5/06 B, 7C 07H 21/00 B, 7C 07H 21/04 B, 7A 61K 48/00 B, 7A 61K 31/70 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20000830 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20030124 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ISIS PHARMACEUTICALS, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20050401 |